http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108586613-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-66
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
filingDate 2018-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108586613-B
titleOfInvention Human antibody targeting CD19 and its preparation and application
abstract The present invention relates to a human antibody targeting CD19, and the sequence information of the variable region of the heavy chain of the human antibody targeting CD19 is shown in SEQ1, SEQ2, SEQ3 and SEQ4 respectively; the human antibody targeting CD19 The sequence information of the variable region of the light chain is shown in SEQ5, SEQ6, SEQ7, SEQ8, and SEQ9, respectively. The CD19-targeting human antibody sequence screened by the present invention can effectively bind to the target protein CD19 and show different affinities. The human antibody can be used for various applications targeting CD19, including chimeric antigens Receptor technology, constructed as a monoclonal antibody to kill tumor cells with ADCC or CDC mechanism, or combined with other antibodies to construct a bispecific antibody.
priorityDate 2018-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004087735-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428545465
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73755215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966228
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20EU8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06SH2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TKU7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1KVQ9

Total number of triples: 28.